1/16
02:45 pm
tlsa
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
Low
Report
Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares
1/16
07:00 am
tlsa
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
High
Report
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
1/9
07:16 am
tlsa
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco [Yahoo! Finance]
Medium
Report
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco [Yahoo! Finance]
1/9
07:00 am
tlsa
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
Medium
Report
Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco
12/29
08:00 am
tlsa
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
Medium
Report
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
12/19
11:00 am
tlsa
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
Medium
Report
Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman
12/17
10:00 am
tlsa
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
Medium
Report
Tiziana Life Sciences to Ring the Closing Bell at Nasdaq
12/17
08:45 am
tlsa
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
Medium
Report
Tiziana Life Sciences Doses First Patient in Phase 2 Alzheimer’s Clinical Trial
12/15
03:07 pm
tlsa
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
High
Report
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
12/15
08:17 am
tlsa
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering [Yahoo! Finance]
High
Report
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering [Yahoo! Finance]
12/15
08:16 am
tlsa
Tiziana Life Sciences withdraws proposed public offering [Seeking Alpha]
High
Report
Tiziana Life Sciences withdraws proposed public offering [Seeking Alpha]
12/15
07:30 am
tlsa
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering
High
Report
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering
12/12
05:32 pm
tlsa
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial [Yahoo! Finance]
Low
Report
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial [Yahoo! Finance]
12/12
02:10 pm
tlsa
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
Medium
Report
Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
12/2
07:00 am
tlsa
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
Medium
Report
Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
11/25
08:30 am
tlsa
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
Medium
Report
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
11/13
08:30 am
tlsa
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
High
Report
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
10/29
07:00 am
tlsa
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy
Medium
Report
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy